Login / Signup

Trends in Canadian prescription drug purchasing: 2001-2020.

Mark HofmeisterAshwinie SivakumarFiona ClementKaleen N HayesMichael LawJason R GuertinHeather L NevilleMina Tadrous
Published in: Journal of pharmaceutical policy and practice (2022)
Identification of the concentration on spending on biologic agents is a key step in managing costs of prescription medications in Canada. Given the increases in spending on biologic agents over the last 20 years, current cost-control mechanisms may be insufficient. Future research efforts should focus on examining the effectiveness of current cost-control mechanisms and identifying new approaches to cost control for biologic agents.
Keyphrases
  • rheumatoid arthritis
  • systematic review
  • emergency department
  • quality improvement
  • drug induced